Product Information
FT ALLERGY (FEXO) 60 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1529 per EA under NDC 70677100801. Its NADAC has been published 152 times since Nov 8, 2023.
FDA first approved this application on Apr 11, 2006.
Strength
60 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677100801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076502FDA Approved
4/11/2006
On Market Since
7/30/2021
Pharmacological Classes
Price Statistics
The NADAC for FT ALLERGY (FEXO) 60 MG TABLET has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1529 per EA |
|---|---|
| All-time high | $0.1994 (Apr 10, 2024) |
| All-time low | $0.1254 (May 22, 2024) |
| 52-week high | $0.1767 |
| 52-week low | $0.1512 |
| Median price | $0.1676 |
| Average price | $0.1661 |
| Largest weekly change | +46.3% (Jun 19, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fexofenadine Hydrochloride 60 mg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fexofenadine Hydrochloride 60 mg market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ALLERGY (FEXO) 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FT ALLERGY (FEXO) 60 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.1529 per EA (NDC 70677100801), effective Sep 30, 2026.
How has the price of FT ALLERGY (FEXO) 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for FT ALLERGY (FEXO) 60 MG TABLET has declined 10.2%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for FT ALLERGY (FEXO) 60 MG TABLET?
Since Nov 8, 2023, the NADAC for FT ALLERGY (FEXO) 60 MG TABLET has ranged from a low of $0.1254 (May 22, 2024) to a high of $0.1994 (Apr 10, 2024), with a median of $0.1676 per EA.
Are there cheaper alternatives to FT ALLERGY (FEXO) 60 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FT ALLERGY (FEXO) 60 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FT ALLERGY (FEXO) 60 MG TABLET?
FT ALLERGY (FEXO) 60 MG TABLET (NDC 70677100801) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.